Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation.

Area of Science:

• Molecular Biology
• Biochemistry
• Structural Biology

Background:

• Epidermal growth factor receptor (EGFR) is crucial for cell growth and survival.
• EGFR mutations, particularly deletions, are linked to non-small cell lung cancer (NSCLC) development.
• Understanding mutation-induced structural changes is key to targeted cancer therapy.

Purpose of the Study:

• To investigate the structural impact of the EGFR Δ746ELREA750 deletion mutation.
• To elucidate how this mutation increases EGFR kinase activity.
• To correlate structural findings with observed drug responses in NSCLC.

Main Methods:

• Molecular dynamics simulations were employed to model wild-type and mutant EGFR.
• Simulations analyzed the conformational stability and dynamics of the EGFR kinase domain.
• Binding interactions with ATP and effects of tyrosine kinase inhibitors were assessed.

Main Results:

• The Δ746ELREA750 deletion stabilizes the active 'αC-in' conformation of the EGFR kinase domain.
• The mutation enhances the stability of a key salt bridge (E762-K745) critical for kinase activity.
• Δ746ELREA750 EGFR exhibits stronger ATP binding and increased sensitivity to active-site inhibitors compared to wild-type.

Conclusions:

• The Δ746ELREA750 deletion promotes a shift towards the active EGFR conformation, prolonging its active state.
• Structural stabilization by the mutation underlies increased kinase activity and therapeutic vulnerability.
• Findings support the mechanism of enhanced efficacy of EGFR inhibitors in NSCLC patients with this mutation.